1. Joris, S, Denys, H, Collignon, J, Aftimos, P, De Grève, J. 2023. Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study. In ESMO open, 8, 102041. doi:10.1016/j.esmoop.2023.102041. https://pubmed.ncbi.nlm.nih.gov/37852034/
2. Di Monaco, Silvia, Georges, Adrien, Lengelé, Jean-Philippe, Vikkula, Miikka, Persu, Alexandre. 2018. Genomics of Fibromuscular Dysplasia. In International journal of molecular sciences, 19, . doi:10.3390/ijms19051526. https://pubmed.ncbi.nlm.nih.gov/29883369/
3. Zuo, Li, Zhang, Fengchun, Xu, Yingchun. 2019. Anti-EGF antibody cationic polymeric liposomes for delivery of the p53 gene for ovarian carcinoma therapy. In International journal of clinical and experimental pathology, 12, 205-211. doi:. https://pubmed.ncbi.nlm.nih.gov/31933735/
4. Raven, Lesley-Ann, Cocks, Benjamin G, Kemper, Kathryn E, Goddard, Michael E, Hayes, Ben J. 2015. Targeted imputation of sequence variants and gene expression profiling identifies twelve candidate genes associated with lactation volume, composition and calving interval in dairy cattle. In Mammalian genome : official journal of the International Mammalian Genome Society, 27, 81-97. doi:10.1007/s00335-015-9613-8. https://pubmed.ncbi.nlm.nih.gov/26613780/
5. Jones, Lamont R, Greene, Joshua, Chen, Kang Mei, Datta, Indrani, Worsham, Maria J. 2016. Biological significance of genome-wide DNA methylation profiles in keloids. In The Laryngoscope, 127, 70-78. doi:10.1002/lary.26063. https://pubmed.ncbi.nlm.nih.gov/27312686/
6. Casto-Rebollo, Cristina, Argente, María José, García, María Luz, Blasco, Agustín, Ibáñez-Escriche, Noelia. 2021. Selection for environmental variance of litter size in rabbits involves genes in pathways controlling animal resilience. In Genetics, selection, evolution : GSE, 53, 59. doi:10.1186/s12711-021-00653-y. https://pubmed.ncbi.nlm.nih.gov/34256696/
7. Demaret, Tanguy, Wintjens, René, Sana, Gwenaelle, Benoit, Valerie, Maystadt, Isabelle. 2022. Case Report: Inactivating PTH/PTHrP Signaling Disorder Type 1 Presenting With PTH Resistance. In Frontiers in endocrinology, 13, 928284. doi:10.3389/fendo.2022.928284. https://pubmed.ncbi.nlm.nih.gov/35846276/